Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy

JE Kaplan, D Hanson, MS Dworkin… - Clinical infectious …, 2000‏ - academic.oup.com
The incidence of nearly all AIDS-defining opportunistic infections (OIs) decreased
significantly in the United States in the years 1992–1998; decreases in the most common …

Adherence to HAART regimens

M Chesney - AIDS patient care and STDs, 2003‏ - liebertpub.com
The problem of inadequate adherence to prescribed highly active antiretroviral therapy
(HAART) drug regimens to treat HIV infection and AIDS is ubiquitous. Adherence can be …

Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments

MA Chesney, JR Ickovics, DB Chambers, AL Gifford… - AIDS care, 2000‏ - Taylor & Francis
This paper describes the AACTG Adherence Instruments, which are comprised of two self-
report questionnaires for use in clinical trials conducted by the Adult AIDS Clinical Trials …

Antiretroviral-drug resistance among patients recently infected with HIV

SJ Little, S Holte, JP Routy, ES Daar… - … England Journal of …, 2002‏ - Mass Medical Soc
Background Among persons in North America who are newly infected with the human
immunodeficiency virus (HIV), the prevalence of transmitted resistance to antiretroviral drugs …

Sociodemographic and psychological variables influencing adherence to antiretroviral therapy

V Gordillo, J del Amo, V Soriano, J González-Lahoz - Aids, 1999‏ - journals.lww.com
Objective: To assess the degree of compliance with antiretroviral therapy in HIV-infected
patients, and identify which sociodemographic and psychological factors influence it, in …

Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease.

SL Catz, JA Kelly, LM Bogart, EG Benotsch… - Health …, 2000‏ - psycnet.apa.org
New treatments for HIV can improve immune functioning and decrease mortality. However,
lapses in adherence may render these complex regimens ineffective. Sixty-three men and 9 …

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

GM Lucas, RE Chaisson, RD Moore - Annals of internal medicine, 1999‏ - acpjournals.org
Background: In clinical trials, highly active antiretroviral therapy (HAART) reduces plasma
HIV-1 RNA levels to less than 500 copies/mL in 60% to 90% of patients with HIV-1 infection …

A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1

CJ Petropoulos, NT Parkin, KL Limoli… - Antimicrobial agents …, 2000‏ - journals.asm.org
Although combination antiretroviral therapy has resulted in a considerable improvement in
the treatment of human immunodeficiency virus (HIV) type 1 (HIV-1) infection, the …

Prevention of resistance: a goal for dose selection for antimicrobial agents

GL Drusano - Clinical infectious diseases, 2003‏ - academic.oup.com
Drug-resistant microorganisms have become a major problem around the world. In
nosocomial and community settings, many important pathogens have demonstrated high …

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up

RS Hogg, K Heath, D Bangsberg, B Yip, N Press… - Aids, 2002‏ - journals.lww.com
Results As of 30 September 2000, 106 subjects had died. Cumulative mortality was
3.9%(±0.5%) at 12 months. In a multivariate model, after controlling for other variables that …